Ospedale Infantile Regina Margherita
- Address
- Piazza Polonia 94, 10126 Turin, Italy
Oncohematology and Pediatric Cancer Research
At Ospedale Infantile Regina Margherita, clinical research in neoplasms is centered on childhood blood cancers, especially Acute Lymphoblastic Leukemia (ALL). These studies are designed to evaluate whether new treatment approaches can improve outcomes for children with relapsed disease and support more effective care in pediatric oncology.
- Testing a new therapy strategy for high-risk relapsed ALL
- Improving treatment effectiveness in pediatric leukemia
- Focusing on better disease control for children with B-cell precursor acute lymphoblastic leukemia
This area reflects the site’s strong role in advancing pediatric oncology research through studies aimed at finding more effective options for children with difficult-to-treat leukemia.
Pediatric Infectious Disease Studies
Research in bacterial infections at this site focuses on children with suspected or confirmed Gram negative infections. The trials are evaluating how well a treatment is handled by the body and whether it is tolerated in young patients, with the broader goal of supporting safer and more effective infection care.
- Assessing treatment handling in the body for serious pediatric infections
- Evaluating safety and tolerability in children with Gram negative infections
- Supporting improved care for infectious diseases in paediatric patients
This work contributes to better understanding of therapies used in children with serious infections, helping guide more appropriate treatment choices in pediatric infectious disease care.
Rare Congenital and Genetic Disorder Research
The site also conducts studies in congenital, hereditary, and neonatal diseases, with a focus on PIK3CA Related Overgrowth Spectrum and other PIK3CA-driven malformations. These trials are exploring new treatment options for rare conditions in order to better understand symptom control and disease response.
- Evaluating a potential therapy for PIK3CA-related overgrowth spectrum
- Studying treatment effects in genetic overgrowth and malformation disorders
- Seeking better options for children with rare developmental conditions
This research supports progress in rare disease care by examining whether targeted approaches can improve outcomes for children affected by PIK3CA mutation-driven disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Menarini Ricerche S.p.A.1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ospedale Infantile Regina Margherita
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Pediatric Patients with Complicated Urinary Tract Infections | Menarini Ricerche S.p.A. | Phase II | Recruiting | Jan 2025 | — |
IMP list
lock Showing 1 of 11 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Crisantaspase | 1 | Unknown | 2023-05-13 | 2023-05-13 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.